|
TMEM69 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.740400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.417090E-03 |
| Normal-vs-Stage2 |
1.250550E-01 |
| Normal-vs-Stage3 |
2.302800E-01 |
| Normal-vs-Stage4 |
8.230100E-02 |
| Stage1-vs-Stage2 |
5.094200E-01 |
| Stage1-vs-Stage3 |
7.044000E-02 |
| Stage1-vs-Stage4 |
4.563600E-01 |
| Stage2-vs-Stage3 |
5.536000E-01 |
| Stage2-vs-Stage4 |
9.695200E-01 |
| Stage3-vs-Stage4 |
5.513000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.896200E-02 |
| Normal-vs-AfricanAmerican |
2.050000E-01 |
| Normal-vs-Asian |
1.037670E-03 |
| Caucasian-vs-AfricanAmerican |
8.909200E-01 |
| Caucasian-vs-Asian |
4.969700E-02 |
| AfricanAmerican-vs-Asian |
1.547380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.920700E-03 |
| Normal-vs-Female |
1.286180E-02 |
| Male-vs-Female |
2.635000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583960E-03 |
| Normal-vs-Age(41-60Yrs) |
3.305900E-02 |
| Normal-vs-Age(61-80Yrs) |
9.174400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.265200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.342400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.822640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.235400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.866800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.053900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.062000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.108400E-01 |
| Classical-VS-Follicular |
2.317800E-01 |
| Classical-VS-Other |
5.289600E-01 |
| Classical-VS-Normal |
4.056000E-03 |
| Tall-VS-Follicular |
7.322800E-01 |
| Tall-VS-Other |
4.919800E-01 |
| Tall-VS-Normal |
9.527900E-02 |
| Follicular-VS-Other |
3.615200E-01 |
| Follicular-VS-Normal |
9.482100E-02 |
| Other-VS-Normal |
6.141600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.124200E-02 |
| Normal-vs-N1 |
1.646750E-01 |
| N0-vs-N1 |
8.650000E-01 |
|
|
